Trials / Completed
CompletedNCT04146493
Heparin-Binding Protein and Heparins
Heparin-binding Protein and Heparins
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Halla Halldorsdottir · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Heparin-Binding protein is a protein from primary and secretory granluae of white blood cells. It is released when white blood cells become activated and has been advocated as a biomarker for sepsis. The aim of this study is to find out if Heparins in clinical doses can change the level of Heparin-binding protein in plasma.
Detailed description
Blood samples are taken from patients before and after Heparins in clinical doses. The effects of heparins on Heparin-binding protein concentration in plasma is measured. This is a small observational study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood samples for Heparin-binding protein measurement | Blood samples before and after given heparin |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2021-11-30
- Completion
- 2021-11-30
- First posted
- 2019-10-31
- Last updated
- 2023-11-18
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04146493. Inclusion in this directory is not an endorsement.